Saturday, July 11, 2026

pharma · Apnea of Prematurity · Safety and Pharmacokinetics

BELPHARMA

BELPHARMA patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Luxembourg, LU HQ
2011 Founded
16 Employees
EMA registrant Type
Company details
Status
Public
HQ
Luxembourg, LU
Founded
2011
Employees
16
Programs
3
Drugs
2
Patents
0
Intelligence · Patents

BELPHARMA patents

0 pharmaceutical patents indexed for BELPHARMA. 0 expire within 24 months.

BELPHARMA has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

No patents matched

Try a different expiry filter or check back as we index more USPTO records.

Frequently asked questions

How many patents does BELPHARMA have?

0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do BELPHARMA patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.